STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost radiation for head and neck cancer
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe and effective for people with advanced head and neck cancer. About 46 adults with certain types of head and neck cancer will receive ipatasertib alongside …
Matched conditions: STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 22:36 UTC
-
New combo therapy aims to shrink tumors in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests two drugs, cabozantinib and nivolumab, in people with advanced melanoma or head and neck cancer that has spread. The goal is to see if the combination can shrink or stabilize tumors, and whether certain biomarkers in the tumor can predict who responds best. About…
Matched conditions: STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New drug plus precision radiation aims to tame recurrent head and neck cancer
Disease control Recruiting nowThis early-stage trial tests a drug called camonsertib combined with precise radiation for head and neck cancer that has returned or cannot be surgically removed. The study aims to find the safest dose and see if the combination can control tumor growth. About 39 adults with cert…
Matched conditions: STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Could skipping chemo after head and neck cancer surgery be just as effective?
Disease control Recruiting nowThis study looks at whether adding the chemotherapy drug cisplatin to standard radiation therapy helps prevent head and neck cancer from coming back after surgery. About 189 people with stage III or IVA squamous cell carcinoma of the head and neck will take part. Researchers will…
Matched conditions: STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 27, 2026 23:06 UTC
-
New drug aims to prevent painful mouth sores in head and neck cancer treatment
Symptom relief Recruiting nowThis study tests whether adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 participants will receive either BMX-001 or a placebo alongside usual mouth rinses and pain medications. The goal is to impro…
Matched conditions: STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
New imaging study reveals hidden vascular damage from radiation therapy
Knowledge-focused Recruiting nowThis study looks at how radiation therapy for head and neck cancers affects blood vessels in the neck. Researchers will use special PET/CT scans to compare two imaging methods. About 20 adults with certain head and neck cancers will take part. The goal is to better understand rad…
Matched conditions: STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:29 UTC
-
Can a simple exercise prevent swallowing problems? study seeks answers.
Knowledge-focused Recruiting nowThis study looks at why some head and neck cancer patients stick with swallowing exercises after radiation, while others don't. Researchers will use blood tests and questionnaires to explore how immune proteins, emotions, and social support affect a patient's ability to follow th…
Matched conditions: STAGE III HYPOPHARYNGEAL CARCINOMA AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC